Inhibition of viral entry by AMD3100 or Maraviroc, which block the co-receptors CXCR4 and CCR548, respectively, together with VSV-G neutralizing antibodies completely abrogated infection and type I IFN induction (Fig. 3a; Supplementary Fig. 5a, b). Here, AQP1 is linked to infection.